+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Organ Function Assays - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 47 Pages
  • December 2021
  • Region: Global
  • GlobalData
  • ID: 5517729
the publisher's Medical Devices sector report, “Organ Function Assays - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Organ Function Assays pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Organ Function Assays comprises of tests or procedure used to evaluate the organ health by measuring the marker concentration of it. They are generally performed at hospitals or home care settings.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


– Extensive coverage of the Organ Function Assays under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Organ Function Assays and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
– Identify and understand important and diverse types of Organ Function Assays under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Organ Function Assays Overview
3 Products under Development
3.1 Organ Function Assays - Pipeline Products by Stage of Development
3.2 Organ Function Assays - Pipeline Products by Territory
3.3 Organ Function Assays - Pipeline Products by Regulatory Path
3.4 Organ Function Assays - Pipeline Products by Estimated Approval Date
3.5 Organ Function Assays - Ongoing Clinical Trials
4 Organ Function Assays - Pipeline Products under Development by Companies
4.1 Organ Function Assays Companies - Pipeline Products by Stage of Development
4.2 Organ Function Assays - Pipeline Products by Stage of Development
5 Organ Function Assays Companies and Product Overview
5.1 Boditech Med Inc Company Overview
5.1.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 China Medical Technologies Inc (Inactive) Company Overview
5.2.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cornell University Company Overview
5.3.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview
5.4 Daxor Corp Company Overview
5.4.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 DSX Therapeutics LLC Company Overview
5.5.1 DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 French National Institute of Health and Medical Research Company Overview
5.6.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.7 HepQuant Llc Company Overview
5.7.1 HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Merck Millipore Corp Company Overview
5.8.1 Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 Myriad Genetics Inc Company Overview
5.9.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Proteome Sciences Plc Company Overview
5.10.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Radboud University Medical Centre Company Overview
5.11.1 Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview
5.12 Schnellgen, Inc Company Overview
5.12.1 Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Organ Function Assays- Recent Developments
6.1 Nov 02, 2021: Myriad Genetics Reports Third Quarter 2021 Results Continues Strong Execution of Strategic Growth & Transformation Plans
6.2 Sep 15, 2021: CareDx Names Longtime Patient Advocate Art Torres to Board of Directors
6.3 Sep 07, 2021: Daxor to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
6.4 Jul 29, 2021: CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance
6.5 Jul 28, 2021: Myriad Genetics Announces that it will hold its quarterly earnings conference call for the quarter ended June 30, 2021
6.6 Jul 28, 2021: Myriad Genetics to Release Second Quarter Financial Results on August 3, 2021
6.7 May 28, 2021: Daxor to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on June 2, 2021
6.8 May 13, 2021: Daxor Announces 61% Increase in Q1 2021 Sales Revenue
6.9 Mar 31, 2021: CareDx Enhances Leadership Team with Key Appointments
6.10 Mar 11, 2021: CareDx Names Ankur Dhingra as New Chief Financial Officer
6.11 Mar 04, 2021: Daxor to Present at the H.C. Wainwright Global Life Sciences Conference
6.12 Feb 26, 2021: Daxor Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020
6.13 Feb 16, 2021: Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021
6.14 Feb 12, 2021: CareDx to Report Fourth Quarter and Full Year 2020 Financial Results
6.15 Feb 11, 2021: Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences
6.16 Feb 10, 2021: CareDx to to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
7 Appendix
7.1 Methodology
7.2 About The Publisher
7.3 Contact Us
7.4 Disclaimer
List of Tables
  • Organ Function Assays - Pipeline Products by Stage of Development
  • Organ Function Assays - Pipeline Products by Territory
  • Organ Function Assays - Pipeline Products by Regulatory Path
  • Organ Function Assays - Pipeline Products by Estimated Approval Date
  • Organ Function Assays - Ongoing Clinical Trials
  • Organ Function Assays Companies - Pipeline Products by Stage of Development
  • Organ Function Assays - Pipeline Products by Stage of Development
  • Glossary

List of Figures
  • Organ Function Assays - Pipeline Products by Stage of Development
  • Organ Function Assays - Pipeline Products by Territory
  • Organ Function Assays - Pipeline Products by Regulatory Path
  • Organ Function Assays - Pipeline Products by Estimated Approval Date
  • Organ Function Assays - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Boditech Med Inc
  • China Medical Technologies Inc (Inactive)
  • Cornell University
  • Daxor Corp
  • DSX Therapeutics LLC
  • French National Institute of Health and Medical Research
  • HepQuant Llc
  • Merck Millipore Corp
  • Myriad Genetics Inc
  • Proteome Sciences Plc
  • Radboud University Medical Centre
  • Schnellgen, Inc